drugset / Trial / NCT06315387
Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral Administration in Healthy Volunteers
Non-randomizedSequentialOpen-labelOther
Summary
Study of safety, tolerability and pharmacokinetic parameters of different doses of 4-MUST, tablets, 128 mg (Valenta Pharm JSC) in healthy volunteers
Timeline
- Start
- 2023-12-04
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 4-methylumbelliferyl trimebutine sulfate | Unknown | 128 mg | Oral |
| Subject | 4-methylumbelliferyl trimebutine sulfate | Unknown | 256 mg | Oral |
| Subject | 4-methylumbelliferyl trimebutine sulfate | Unknown | 384 mg | Oral |